1Chiquet Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress [J]. J Pathol, 2003, 200(4): 488-499.
2Tamura A, Kusachi S, Nogami K, et al. Tenascin expression in endomyocardial biopsy specimens in patients with dilated eardiomyopathy: distribution along margin of fibrotic lesions[J]. Heart, 1996, 75(3): 291-294.
3Adam B, Toth L, Pdsti G, et al. Contact stimulation of fi broblasts for tenascin production by melanoma cells[J]. Mel anoma Res, 2006, 16(5) : 385-391.
4Ballard VL, Sharma A, Duignan I, et al. Vascular tenagcin- C regulates cardiac endothelial phenotype and neovascularization[J].FASEBJ, 2006, 20(6): 717-719.
5Sato A, Aonuma K, Imanaka-Yoshida K, et al. Serum tena scin-C might be a novel predictor of left ventricular remodel- ling and prognosis after acute myocardial infarction[J]. J Am Cell Cardiol, 2006, 47(11): 2319 -2325.
6Tsukada B, Terasaki F, Shimomara H. High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventrieuloplasty expression of tenascin C as a possible marker for inflammation[J]. Hun Pathol, 2009, 40(7) : 1015-1022.
7Nishioka T, Suzuki M, Onishi K, et al. Eplerenone attenu ares myocardial fibrosis in the angiotensin II-induced hyper tensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation [J]. J Cardiovsc Pharmacol, 2007, 49(5): 261-268.
8Yamamoto K, Dang QN, Kennedy SP, et al. Induction of tenasein C in cardiac myocytes by mechanical deformation: Role of reactive oxygen species[J].J Biol Chem, 1999, 274 (31) : 21840-21846.
9Terasaki F, Okarrloto H, Onishi K, et al, Higher serum tenascin C levels reflect the severity of heart failure, left ventrieular dysfunction and remodeling in patient with dilated cardiomyopathy[J]. Circ J, 2007, 71(3): 327-330.
10Aso N, Tamura A, Nasu M. Circulating tenascin-C levels in patient with idiopathic dilated eardiomyopathy [J]. Am J Cardiol, 2004, 94( 11 ) :1468-1470.
